[go: up one dir, main page]

Xiao, 2004 - Google Patents

Prevention of lupus by IL-2 knockout and colitis and anemia by Fas mutation

Xiao, 2004

Document ID
4077441297509804431
Author
Xiao S
Publication year

External Links

Snippet

This thesis addresses the interaction between the Il2 and fas genes in autoimmune disease, anemia, and ulcerative colitis. A defect in the fas gene causes lpr mice to develop a systemic lupus erythematosis (SLE)-like disease. Auto-reactive T cells, which cannot be depleted due …
Continue reading at search.proquest.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Similar Documents

Publication Publication Date Title
Le Mercier et al. Beyond CTLA-4 and PD-1, the generation Z of negative checkpoint regulators
van Olffen et al. GITR triggering induces expansion of both effector and regulatory CD4+ T cells in vivo
Kojima et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes
Lenardo et al. Mature T lymphocyte apoptosis—immune regulation in a dynamic and unpredictable antigenic environment
Tau et al. Biologic functions of the IFN‐γ receptors
US8329660B2 (en) Tim-3 ligands and methods thereof
US20150079085A1 (en) Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
JP5401001B2 (en) Novel compositions and methods for the treatment of immune related diseases
Flodström et al. The natural killer cell–friend or foe in autoimmune disease?
CN110799206A (en) Methods of using soluble CD24 to treat immune-related adverse events in cancer therapy
Dianzani et al. Role of inherited defects decreasing Fas function in autoimmunity
KR100874280B1 (en) Regulation of T Cell Differentiation for Treatment of T Helper Cell Mediated Disease
Xiao Prevention of lupus by IL-2 knockout and colitis and anemia by Fas mutation
WO1999026980A1 (en) Methods and reagents for the utilization of sap family member proteins, novel signal transduction regulators
US7393532B1 (en) Modulation of T cell differentiation for the treatment of T helper cell mediated diseases
CN101027392B (en) Methods of modulating immune responses by modulating TIM-1, TIM-2 and TIM-4 function
Ayensu et al. Molecular and cellular mechanisms associated with autoimmune diseases
Sytwu T cell activation, apoptosis, and autoimmune disease
de Villartay et al. Clinical effects of mutations to CD95 (Fas): relevance to autoimmunity?
Villafana The role of Fas in activation-induced cell death and maintaining peripheral tolerance of lymphocytes
GREGORY 11 Apoptosis in the Immune System
Conrad et al. Evidence for superantigen
Peritt Functional and phenotypic analysis of human cytotoxic cell subsets
Tau Regulation of interferon γ responsiveness in T cells: Effects of ectopic interferon γ signaling
Sutherland BAFF regulation of peripheral T cell responses